Lilly 3977 40 mg Pill: gray, capsule/oblong, 18mm
Generic Name: selpercatinib
The pill with imprint Lilly 3977 40 mg (Gray, Capsule/Oblong, 18mm) has been identified as Retevmo 40 mg and is used for Non Small Cell Lung Cancer, Thyroid Cancer, and Solid Tumors. It belongs to the drug class multikinase inhibitors and is not a controlled substance.
Images for Lilly 3977 40 mg
Retevmo
- Generic Name
- selpercatinib
- Imprint
- Lilly 3977 40 mg
- Strength
- 40 mg
- Color
- Gray
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Eli Lilly and Company
- National Drug Code (NDC)
- 00002-3977
See also:
More about Retevmo (selpercatinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (4)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.